GlassScriptPhysician profile
Gregory Y Warner
NPI 1073704326
$707.51
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.95 · 2021: $64.45 · 2022: $117 · 2023: $203 · 2024: $181 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $97.70 | 2022-2025 | Cabenuva, Apretude |
| Abbvie INC. | $79.27 | 2025 | |
| Scilex Pharmaceuticals INC. | $62.40 | 2024 | |
| Argenx US, INC. | $62.24 | 2023 | Vyvgart Hytrulo, Vyvgart |
| Alexion Pharmaceuticals, INC. | $52.51 | 2023-2024 | Ultomiris |
| Lilly USA, LLC | $49.83 | 2023 | Amyvid |
| Banner Life Sciences, LLC | $48.13 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.34 | 2021-2024 | Entyvio |
| Amgen INC. | $41.64 | 2020-2021 | |
| Eisai INC. | $38.88 | 2022 | |
| Amneal Pharmaceuticals LLC | $28.82 | 2022 | |
| Nestle Healthcare Nutrition INC. | $25.07 | 2023 | |
| Janssen Pharmaceuticals, INC | $23.10 | 2022 | |
| Sk Life Science, INC. | $20.27 | 2021 | |
| Tanabe Pharma America, INC. | $19.47 | 2025 | Radicava |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $14.84 | 2023 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.